Dillon J Dzikowicz PhD, RN, PCCN , Mehmed Aktas , Sunita Pokhrel Bhattarai PhD, RN , Leway Chen MD, MPH , Mary G. Carey PhD, RN, FAHA, FAAN
{"title":"急性失代偿性心力衰竭患者的 \"门到利尿剂时间 \"与住院时间长短有关,与利尿剂剂量无关。","authors":"Dillon J Dzikowicz PhD, RN, PCCN , Mehmed Aktas , Sunita Pokhrel Bhattarai PhD, RN , Leway Chen MD, MPH , Mary G. Carey PhD, RN, FAHA, FAAN","doi":"10.1016/j.hrtlng.2024.11.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Acute decompensated heart failure (ADHF) treatment guidelines recommend initial dosages for diuretic drugs but lack guidance on treatment timing. Recent evidence indicates that faster treatment, or shorter Door-to-Diuretic (D2D) Time, may improve outcomes.</div></div><div><h3>Objectives</h3><div>This study assessed how diuretic dose, D2D Time, and their interaction affect hospital length of stay.</div></div><div><h3>Methods</h3><div>Data were analyzed from medical records of ADHF patients in the emergency department of a large academic center. We calculated the odds of longer hospitalization (>7 days) based on diuretic dose, D2D Time, and their interaction, adjusting for age, sex, race, NYHA class, creatinine levels, systolic blood pressure, and comorbidity burden.</div></div><div><h3>Results</h3><div>Our sample of 198 patients who were hospitalized a total of 275 times (mean: 1.48±0.99 hospitalizations) were predominantly male (57 %), older (71, IQR:18.5), years), overweight/obese (30.12, IQR: 11.66 kg/m<sup>2</sup>), had multiple comorbidities (5.6 ± 2.1), and had a reduced ejection fraction (58 %, <em>n</em> = 159). The median length of hospital stay was 7.0 days (8.0). Peripheral edema was significantly higher among ADHF patients with prolonged hospitalization (28.69% vs. 15.68 %, <em>p</em> = 0.01). D2D Time was a statistically significant predictor of prolonged hospitalization without (OR=1.011609, <em>p</em> = 0.041) and with (OR=1.012409, <em>p</em> = 0.034) covariate adjustment. Neither the diuretic dose nor the interaction between the D2D Time and dose were significant predictors.</div></div><div><h3>Conclusion</h3><div>D2D Time significantly predicts prolonged hospitalization independently of diuretic dosing, highlighting a need for revised ADHF guidelines that include both diuretic dosing and timely administration. Further research is essential to refine these recommendations.</div></div>","PeriodicalId":55064,"journal":{"name":"Heart & Lung","volume":"70 ","pages":"Pages 36-42"},"PeriodicalIF":2.4000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Door-to-Diuretic Time is related to length of hospital stay independent of diuretic dose among acute decompensated heart failure patients\",\"authors\":\"Dillon J Dzikowicz PhD, RN, PCCN , Mehmed Aktas , Sunita Pokhrel Bhattarai PhD, RN , Leway Chen MD, MPH , Mary G. Carey PhD, RN, FAHA, FAAN\",\"doi\":\"10.1016/j.hrtlng.2024.11.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Acute decompensated heart failure (ADHF) treatment guidelines recommend initial dosages for diuretic drugs but lack guidance on treatment timing. Recent evidence indicates that faster treatment, or shorter Door-to-Diuretic (D2D) Time, may improve outcomes.</div></div><div><h3>Objectives</h3><div>This study assessed how diuretic dose, D2D Time, and their interaction affect hospital length of stay.</div></div><div><h3>Methods</h3><div>Data were analyzed from medical records of ADHF patients in the emergency department of a large academic center. We calculated the odds of longer hospitalization (>7 days) based on diuretic dose, D2D Time, and their interaction, adjusting for age, sex, race, NYHA class, creatinine levels, systolic blood pressure, and comorbidity burden.</div></div><div><h3>Results</h3><div>Our sample of 198 patients who were hospitalized a total of 275 times (mean: 1.48±0.99 hospitalizations) were predominantly male (57 %), older (71, IQR:18.5), years), overweight/obese (30.12, IQR: 11.66 kg/m<sup>2</sup>), had multiple comorbidities (5.6 ± 2.1), and had a reduced ejection fraction (58 %, <em>n</em> = 159). The median length of hospital stay was 7.0 days (8.0). Peripheral edema was significantly higher among ADHF patients with prolonged hospitalization (28.69% vs. 15.68 %, <em>p</em> = 0.01). D2D Time was a statistically significant predictor of prolonged hospitalization without (OR=1.011609, <em>p</em> = 0.041) and with (OR=1.012409, <em>p</em> = 0.034) covariate adjustment. Neither the diuretic dose nor the interaction between the D2D Time and dose were significant predictors.</div></div><div><h3>Conclusion</h3><div>D2D Time significantly predicts prolonged hospitalization independently of diuretic dosing, highlighting a need for revised ADHF guidelines that include both diuretic dosing and timely administration. Further research is essential to refine these recommendations.</div></div>\",\"PeriodicalId\":55064,\"journal\":{\"name\":\"Heart & Lung\",\"volume\":\"70 \",\"pages\":\"Pages 36-42\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart & Lung\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0147956324002097\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart & Lung","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0147956324002097","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Door-to-Diuretic Time is related to length of hospital stay independent of diuretic dose among acute decompensated heart failure patients
Background
Acute decompensated heart failure (ADHF) treatment guidelines recommend initial dosages for diuretic drugs but lack guidance on treatment timing. Recent evidence indicates that faster treatment, or shorter Door-to-Diuretic (D2D) Time, may improve outcomes.
Objectives
This study assessed how diuretic dose, D2D Time, and their interaction affect hospital length of stay.
Methods
Data were analyzed from medical records of ADHF patients in the emergency department of a large academic center. We calculated the odds of longer hospitalization (>7 days) based on diuretic dose, D2D Time, and their interaction, adjusting for age, sex, race, NYHA class, creatinine levels, systolic blood pressure, and comorbidity burden.
Results
Our sample of 198 patients who were hospitalized a total of 275 times (mean: 1.48±0.99 hospitalizations) were predominantly male (57 %), older (71, IQR:18.5), years), overweight/obese (30.12, IQR: 11.66 kg/m2), had multiple comorbidities (5.6 ± 2.1), and had a reduced ejection fraction (58 %, n = 159). The median length of hospital stay was 7.0 days (8.0). Peripheral edema was significantly higher among ADHF patients with prolonged hospitalization (28.69% vs. 15.68 %, p = 0.01). D2D Time was a statistically significant predictor of prolonged hospitalization without (OR=1.011609, p = 0.041) and with (OR=1.012409, p = 0.034) covariate adjustment. Neither the diuretic dose nor the interaction between the D2D Time and dose were significant predictors.
Conclusion
D2D Time significantly predicts prolonged hospitalization independently of diuretic dosing, highlighting a need for revised ADHF guidelines that include both diuretic dosing and timely administration. Further research is essential to refine these recommendations.
期刊介绍:
Heart & Lung: The Journal of Cardiopulmonary and Acute Care, the official publication of The American Association of Heart Failure Nurses, presents original, peer-reviewed articles on techniques, advances, investigations, and observations related to the care of patients with acute and critical illness and patients with chronic cardiac or pulmonary disorders.
The Journal''s acute care articles focus on the care of hospitalized patients, including those in the critical and acute care settings. Because most patients who are hospitalized in acute and critical care settings have chronic conditions, we are also interested in the chronically critically ill, the care of patients with chronic cardiopulmonary disorders, their rehabilitation, and disease prevention. The Journal''s heart failure articles focus on all aspects of the care of patients with this condition. Manuscripts that are relevant to populations across the human lifespan are welcome.